Comparative Efficacy of Etiotropic Therapy of Patients with HBeAg-Positive Chronic Hepatitis B (by the Data of the International Comparative Placebo-Controlled Study)

Comparative placebo-controlled study entrolled 647 patients with verified diagnosis of chronic virus hepatitis B (HBeAg+), not previously subjected to antiviral therapy (with nucleotide analogues or interferons). The drug under the investigation was cycloferon, an earlier interferon inductor. The an...

Descripció completa

Dades bibliogràfiques

Autors principals:	V. V. Stelmakh, M. G. Romantsov, T. V. Sologub, A. A. Shuldyakov, V. K. Kozlov, N. Kh. Tuan, M. .. Ovungerel, V. M. Frolov
Format:	Artigo
Idioma:	Russo
Publicat:	LLC "Publishing House OKI" 2020-05-01
Col·lecció:	Антибиотики и Химиотерапия
Matèries:	hbv hbeag+ chronic virus hepatitis b interferon inductor antivirals lamivudine cycloferon
Accés en línia:	https://www.antibiotics-chemotherapy.ru/jour/article/view/507
Etiquetes:	Afegir etiqueta Sense etiquetes, Sigues el primer a etiquetar aquest registre!